Bristol John W & CO Inc Pfizer Inc Transaction History

Bristol John W & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $17,869 - $23,326	-428 Reduced 3.72%	11,070 $0
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $18,729 - $22,863	428 Added 3.87%	11,498 $503,000
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $351,472 - $412,357	11,070 New	11,070 $406,000
Q1 2019 Apr 12, 2019	SELL	$37.5 - $41.2 $197,325 - $216,794	-5,262 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $461 - $526	12 Added 0.23%	5,262 $230,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $167,527 - $194,355	5,250 New	5,250 $186,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bristol John W & CO Inc , based on Form 13F filings with the SEC.

Stay updated on Bristol John W & CO Inc with notifications on news.